Oncolytics Biotech data at ASCO 2026: pelareorep virus activates T cells against mutant KRAS in pancreatic cancer. Learn about the breakthrough in treating 'cold' tumors.
Mount Sinai scientists refuted the dogma of mRNA vaccine function. Suppressing expression in the liver triples the immune response. Learn about the revolution in cancer therapy and toxicity reduction.
Russian scientists replaced expensive gold with tungsten and palladium diselenides for photothermal cancer therapy. Learn about a cheap and safe method for destroying inoperable tumors.
The drug daraxonacib doubled survival in pancreatic cancer but does not cure. Learn about mechanisms, side effects, and real limits of the breakthrough. Read the analysis.
GPS Platform Analyzes Molecules to Find Treatments for HCC and IPF. Tests on Mice and Tissues Confirmed Efficacy. Open the Code and Apply to Your Tasks in drug discovery.
MIT scientists have created nanoparticles with AND logic for targeted activation of the STING pathway in metastases. Preclinical data: 70% reduction in metastases. Learn about the breakthrough in nanomedicine.
Scientists have proven: CD4+ T lymphocytes destroy MHC I-negative tumors through ferroptosis. The discovery changes the approach to cancer immunotherapy and treatment of GVHD. Read the details.
TransCODE scientists discovered over 1700 microproteins in non-coding DNA. Silencing the OLMALINC gene reduces cancer cell survival by 85%. Learn how peptideins are changing oncology and immunotherapy.
Scientists have discovered over 1700 microproteins in non-coding DNA, becoming new targets for cancer. Learn how peptideins change immunotherapy and oncovaccines. Read breakthrough details!
Mechanism of ruptosis discovered: kamikaze cells explode, destroying tumors locally. Learn how this will change cancer immunotherapy and infection control.
mRNA drug mRNA-4359 with Keytruda showed 83% response and 17% complete remissions. Even PD-L1-negative tumors shrank. Learn how a ready-made vaccine teaches the immune system to attack cancer without personalization.
FDA approved durvalumab with BCG for high-risk NMIBC. POTOMAC data: 32% risk reduction. Analysis of efficacy, toxicity, and consequences of BCG shortage. Learn more.
Analysis of the efficacy of encorafenib and binimetinib combination in BRAF-mutant colorectal cancer. Results, limitations, prognosis, and side effects. Read more.
Analysis of the NRG-GY018 study: pembrolizumab + chemotherapy improved survival in endometrial cancer. Risk of death reduced by 44% in dMMR. Details at ASCO 2026.
Europe approved the world's first Lurbinectedin drug with immunotherapy for aggressive lung cancer. 46% reduction in risk of death. Learn about the breakthrough and forecasts.
From the web
Cancer - Wikipedia
https://en.wikipedia.org/wiki/Cancer
Cancer is a group of diseases involving uncontrolled cell growth typically resulting in tumors with the potential to invade or spread to …